Reduced impact of migraine in everyday life: An observational study in the Dutch Society of Headache Patients

Headache

Volumn 43, Issue 6, 2003, Pages 645-650

  Vos, J ^b   Passchier, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Coping; Migraine; Quality of life

Indexed keywords

ACETYLSALICYLIC ACID; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ERGOTAMINE; IBUPROFEN; MIGRAFIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SUMATRIPTAN SUCCINATE; UNCLASSIFIED DRUG;

ARTICLE; COPING BEHAVIOR; DISEASE SEVERITY; FAMILY; HEADACHE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MIGRAINE; MIGRAINE SPECIFIC QUALITY OF LIFE INSTRUMENT; NETHERLANDS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL SUPPORT; STRESS;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NETHERLANDS; QUALITY OF LIFE; QUESTIONNAIRES; RANDOM ALLOCATION; SEROTONIN AGONISTS; SOCIAL SUPPORT;

EID: 0038001072     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03107.x     Document Type: Article

References (14)

1. Dahlof CG, Dimenas E. Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia. 1995;15:31-36.
2. Osterhaus JT, Townsend RJ. The quality of life of migraineurs: A crosssectional profile. Cephalalgia. 1991;11(suppl 11):103-104.
3. Essink-Bot ML, van Royen L, Krabbe P, Bonsel GJ, Rutten FF. The impact of migraine on health status. Headache. 1995;35:200-206.
4. Passchier J, de Boo M, Quaak HZ, Brienen JA. Health-related quality of life of chronic headache patients is predicted by the emotional component of their pain. Headache. 1996;36:556-560.
5. Passchier J, Mourik J, Brienen JA, Hunfeld JA. Cognitions, emotions, and behavior of patients with migraine when taking medication during an attack. Headache. 1998;38:458-464.
6. Mushet GR, Miller D, Clements B, Pait G, Gutterman DL. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Headache. 1996;36:137-143.
7. Dulli DA. Naratriptan: an alternative for migraine. Ann Pharmacother. 1999;33:704-711.
8. Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain. 1999;80:1-13.
9. McKenna SP, Doward LC, Mackenzie DK. The development and psychometric properties of the MSQOL; a migraine-specific quality-of-life instrument. Clin Drug Invest. 1998;15:413-423.
10. Passchier J, Mourik JC, McKenna SP, van der Berg M, Erdman RA. Evaluation of the Dutch version of the Migraine Quality of Life instrument (MSQOL) and its application in headache coping. Cephalalgia. 2001;21:823-829.
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
12. Lipton RB, Stewart WC, Solomon S. Questionnaire versus clinical interview in the diagnosis of headache [letter to the editor]. Headache. 1992;32:55-56.
13. Reid GJ, McGrath PJ. Psychological treatments for migraine. Biomed Pharmacother. 1996;50:58-63.
14. Scopp AL. Headache triggers: Theory, research, and clinical application: part I. Headache Q. 1992;3:32-38.